Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 195167011000036111 | Reminyl (galantamine 8 mg) modified release capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 195168011000036112 | Reminyl 8 mg modified release capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Reminyl 8 mg modified release capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Reminyl 8 mg modified release capsule | Is a | Reminyl | true | Inferred relationship | Some | ||
| Reminyl 8 mg modified release capsule | Is a | galantamine 8 mg modified release capsule | true | Inferred relationship | Some | ||
| Reminyl 8 mg modified release capsule | has Australian BoSS | galantamine | true | Inferred relationship | Some | 418981966 | |
| Reminyl 8 mg modified release capsule | has manufactured dose form | modified release capsule | true | Inferred relationship | Some | ||
| Reminyl 8 mg modified release capsule | has unit of use | capsule | true | Inferred relationship | Some | 418981967 | |
| Reminyl 8 mg modified release capsule | has intended active ingredient | galantamine | true | Inferred relationship | Some | 418981966 |
Reference Sets
Trade product unit of use reference set
FHIR